Viatris (VTRS) Non-Current Assets (2019 - 2026)

Viatris (VTRS) recorded quarterly Non-Current Assets of $25.9 billion in Q1 2026, down 5.42% quarter-over-quarter from $27.4 billion in Q4 2025, and down 10.17% on a YoY basis from $28.9 billion in Q1 2025.

Viatris (VTRS) Non-Current Assets (2019 - 2026) Analysis & Trends

Viatris' Non-Current Assets history runs 8 years deep, the most recent figure standing at $25.9 billion for Q1 2026.

  • In Q1 2026, Non-Current Assets fell 10.17% year-over-year to $25.9 billion; the TTM figure through Mar 2026 stood at $109.9 billion (down 14.0% YoY), while the FY2025 annual figure was $27.4 billion, down 14.31% from the prior year.
  • Non-Current Assets was $25.9 billion for Q1 2026 at Viatris, down from $27.4 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $41.7 billion in Q1 2022 to a low of $25.9 billion in Q1 2026.
  • Historically, Non-Current Assets has averaged $34.3 billion across 5 years, with a median of $34.4 billion in 2024.
  • The sharpest annual moves came in 2022 and 2025: Non-Current Assets surged 7877260.0% in 2022, then declined 16.38% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $39.4 billion in 2022, then decreased by 11.88% to $34.7 billion in 2023, then declined by 7.86% to $32.0 billion in 2024, then dropped by 14.31% to $27.4 billion in 2025, then retreated by 5.42% to $25.9 billion in 2026.
  • The last three Non-Current Assets figures came in at $25.9 billion (Q1 2026), $27.4 billion (Q4 2025), and $28.0 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 26.33 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 8.68 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 3.84 Bn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 2.47 Bn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 9.64 Bn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 2.90 Bn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 1.40 Bn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 1.22 Bn
10 Viatris - - 1.16 Bn 25.92 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 25.92 Bn
Dec 31, 2025 27.40 Bn
Sep 30, 2025 27.97 Bn
Jun 30, 2025 28.64 Bn
Mar 31, 2025 28.85 Bn
Dec 31, 2024 31.98 Bn
Sep 30, 2024 33.45 Bn
Jun 30, 2024 33.54 Bn
Mar 31, 2024 34.42 Bn
Dec 31, 2023 34.71 Bn
Sep 30, 2023 37.81 Bn
Jun 30, 2023 38.92 Bn
Mar 31, 2023 39.66 Bn
Dec 31, 2022 39.39 Bn
Sep 30, 2022 38.17 Bn
Jun 30, 2022 39.95 Bn
Mar 31, 2022 41.72 Bn
Dec 31, 2021 500,000.00
Sep 30, 2021 44.76 Bn
Jun 30, 2021 46.23 Bn